Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Perceptive Advisors
MedTech
Freenome to go public in $330M SPAC deal
Backed by an affiliate of Perceptive Advisors and joined by RA Capital, the move includes a commitment of $240 million in equity investments.
Conor Hale
Dec 5, 2025 10:35am
Endeavor nabs $101M for IPF, cancer trials—and asset shopping
Feb 7, 2022 8:00am
Mystery revealed: Mythic lands $103M to take on ADC class
Dec 16, 2021 10:30am
Amicus spins off gene therapy unit in $600M SPAC deal
Sep 29, 2021 8:35am
Takeda norovirus vaccine spinout HilleVax snags $135M crossover
Sep 8, 2021 10:25am
Portable test maker Cue Health nets $235M for a post-COVID world
May 13, 2021 1:20pm
